Australian Clinical Labs Limited provided earnings guidance for the fiscal year of 2021. For the year, the company expected Total revenue to be between $657.7 million - $663.3 million compared to $647.0 million of previous guidance. EBIT to be between $129.9 million - $134.7 million compared to $207.7 million in previous guidance. NPAT to be $82.0 million - $85.4 million compared to $74.5 million in previous guidance.